BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs4950928, EGFR, Metabolism of xenobiotics, Arthritis, Heart, Laryngoscope, Vitamin E)
Bookmark Forward

QuickView for B7-H3 (gene)


Body Atlas

Most Correlated Tissues

  1. Saphenous vein
  2. Vena cava
  3. Colon
  4. Adrenal gland cortex
  5. Heart ventricle
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Placental insufficiency
  2. Edema
  3. Injury of external ear
  4. Fetal growth restriction
  5. Duchenne muscular dystrophy
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Foscarnet
  2. cineole
  3. Stavudine
  4. pantoprazole
  5. Chloroform
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR29A
  2. ADAMTS9
  3. RCOR1
  4. HOXC6
  5. SF3A2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. B7-H3 blockade decreases macrophage inflammatory response and alleviates clinical symptoms of arthri…
  2. B7H3 expression and significance in idiopathic pulmonary fibrosis.
  3. Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-depe…
  4. B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the …
  5. ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregu…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Safety Study of MGD009 in B7-H3-expressing Tumors
  2. Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
  3. Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors
  4. Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
  5. Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
Explore Clinical Trials Results
  • Copyright © 2022 Illumina Inc. All rights reserved.